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A structured training programme for caregivers of inpatients 
after stroke (TRACS): a cluster randomised controlled trial 
and cost-eﬀ ectiveness analysis
Anne Forster, Josie Dickerson, John Young, Anita Patel, Lalit Kalra, Jane Nixon, David Smithard, Martin Knapp, Ivana Holloway, Shamaila Anwar, 
Amanda Farrin, on behalf of the TRACS Trial Collaboration
Summary
Background Most patients who have had a stroke are dependent on informal caregivers for activities of daily living. 
The TRACS trial investigated a training programme for caregivers (the London Stroke Carers Training Course, 
LSCTC) on physical and psychological outcomes, including cost-eﬀ ectiveness, for patients and caregivers after a 
disabling stroke.
Methods We undertook a pragmatic, multicentre, cluster randomised controlled trial with a parallel cost-eﬀ ectiveness 
analysis. Stroke units were eligible if four of ﬁ ve criteria used to deﬁ ne a stroke unit were met, a substantial  number 
of patients on the unit had a diagnosis of stroke, staﬀ  were able to deliver the LSCTC, and most patients were 
discharged to a permanent place of residence. Stroke units were randomly assigned to either LSCTC or usual care 
(control group), stratiﬁ ed by geographical region and quality of care, and using blocks of size 2. Patients with a 
diagnosis of stroke, likely to return home with residual disability and with a caregiver providing support were eligible. 
The primary outcome for patients was self-reported extended activities of daily living at 6 months, measured with the 
Nottingham Extended Activities of Daily Living (NEADL) scale. The primary outcome for caregivers was self-reported 
burden at 6 months, measured with the caregivers burden scale (CBS). We combined patient and caregiver costs with 
primary outcomes and quality-adjusted life-years (QALYs) to assess cost-eﬀ ectiveness. This trial is registered with 
controlled-trials.com, number ISRCTN 49208824.
Findings We assessed 49 stroke units for eligibility, of which 36 were randomly assigned to either the intervention 
group or the control group. Between Feb 27, 2008, and Feb 9, 2010, 928 patient and caregiver dyads were registered, 
of which 450 were in the intervention group, and 478 in the control group. Patients’ self-reported extended activities 
of daily living did not diﬀ er between groups at 6 months (adjusted mean NEADL score 27·4 in the intervention group 
versus 27·6 in the control group, diﬀ erence –0·2 points [95% CI –3·0 to 2·5], p value=0·866, ICC=0·027). The 
caregiver burden scale did not diﬀ er between groups either (adjusted mean CBS 45·5 in the intervention group 
versus 45·0 in the control group, diﬀ erence 0·5 points [95% CI –1·7 to 2·7], p value=0·660, ICC=0·013). Patient and 
caregiver costs were similar in both groups (length of the initial stroke admission and associated costs were £13 127 
for the intervention group and £12 471 for the control group; adjusted mean diﬀ erence £1243 [95% CI –1533 to 4019]; 
p value=0·380). Probabilities of cost-eﬀ ectiveness based on QALYs were low.
Interpretation In a large scale, robust evaluation, results from this study have shown no diﬀ erences between the 
LSCTC and usual care on any of the assessed outcomes. The immediate period after stroke might not be the ideal 
time to deliver structured caregiver training.
Funding Medical Research Council.
Introduction
Stroke is a common condition with an estimated yearly 
incidence for ﬁ rst-ever occurrence of 1·65 per 
1000 population.1 Immediate admission to hospital for 
treatment and rehabilitation is recommended, however, 
most patients return home with some residual disability.2 
Substantial reliance and burden is placed on informal 
caregivers, usually family members, to provide assistance 
with activities of daily living, including dressing and 
toileting after hospital discharge,3 which can aﬀ ect 
caregivers’ physical and psychosocial wellbeing.4,5 The 
economic value of the informal care provided is 
substantial.6,7 Eﬀ ective interventions directed at care givers 
of patients who have had a stroke are important both to 
sustain their own health and to improve the recovery and 
adjustment of the patient who has had a stroke.8,9
A systematic, structured training programme for 
caregivers, delivered in a stroke unit, which included 
assessment of competencies in skills essential for the 
day-to-day management of disabled stroke survivors (the 
London Stroke Carers Training Course, LSCTC) was 
developed and assessed in a single-centre individually 
randomised trial.10 Results from this trial10 reported a 
decrease in caregiver burden, anxiety, and depression, 
improved psychological outcomes for patients, and 
reduced overall costs largely due to earlier hospital 
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discharge following the LSCTC compared with usual 
care.11 We established the training caregivers after stroke 
(TRACS) trial to investigate the wider generalisability of 
the LSCTC intervention and to assess the eﬀ ectiveness of 
the LSCTC in improving physical outcomes for the 
patient and reducing caregiver burden.
Methods
Study design and participants
TRACS was a UK, pragmatic, multicentre cluster 
randomised trial of the LSCTC. We purposely selected 
the cluster randomised trial design to reduce between-
group treatment contamination. Methods have been 
reported in detail elsewhere.12 In summary, stroke units 
were eligible if: four of ﬁ ve criteria used to deﬁ ne a stroke 
unit were met;13 a substantial number of patients on the 
unit had a diagnosis of stroke; staﬀ  were able to deliver 
the LSCTC; and most patients were discharged to a 
permanent place of residence. We also undertook an 
embedded process evaluation that will be reported 
separately.
In keeping with the pragmatic trial design, eligibility 
criteria were deliberately broad and inclusive. Patients 
were eligible for participation if they had a conﬁ rmed 
primary diagnosis of new stroke (ischaemic or intra-
cerebral haemorrhage; ﬁ rst or recurrent stroke); were 
medically stable, likely to return home with residual 
disability; and, following discharge, had a caregiver 
available, willing and able to provide support. We deﬁ ned 
the caregiver as the main person, other than health, 
social, or voluntary care provider, helping with activities 
of daily living or advocating on behalf of the patient. We 
excluded patient and caregiver dyads if the patient 
needed palliative care, discharge was planned within 
1 week of admission to the stroke unit (insuﬃ  cient time 
for exposure to the intervention), or the patient or 
caregiver was previously registered to the trial.
All participants provided written informed consent or 
assent for participation in the trial. The study protocol 
was approved by Leeds Research Ethics Committee 
(reference 07/Q1205/12), and accepted by The Lancet.
Randomisation and masking
Cluster randomisation was done centrally at the Clinical 
Trials Research Unit (CTRU). Stroke units were randomly 
assigned (1:1) to either the intervention group or the 
control group, stratiﬁ ed by geographical region and 
quality of care (deﬁ ned as being on and above or below 
the median on the key 12 indicator score of the 2006 
National Sentinel Audit).13 We used block randomisation 
(blocks of size 2) to ensure these important covariates 
were balanced between the arms of the trial.
Researchers independent of clinical teams delivering 
patient care undertook participant recruitment and 
collection of baseline data. We completed detailed 
screening logs throughout the trial to monitor for selection 
bias. Participants were masked to the stroke unit allocation.
Procedures
The LSCTC is a structured training programme for 
caregivers, which includes assessment of competencies in 
knowledge or skills essential for the day-to-day manage-
ment of disabled survivors of stroke (for example, 
knowledge of stroke, handling skills for activities of daily 
living). The programme has 14 components, six com-
ponents are mandatory, eight non-mandatory dependent 
on individual patient and caregiver needs (appendix). 
Caregivers’ competency can be checked by observing the 
skill, or questioning their understanding. The LSCTC was 
modiﬁ ed for national rollout by the multidisciplinary 
team who delivered the LSCTC in the single-centre study.10 
They developed an intervention manual and caregiver 
training record, and devised and delivered a training 
programme to members of the multidisciplinary team in 
intervention sites through centrally organised training 
days. Staﬀ  attending the training were tasked with 
cascading the LSCTC to other members of the multi-
disciplinary team and were provided with materials (slides 
and recordings of talks) to support them in doing so. 
Subsequently, staﬀ  were to gradually increase delivery of 
the LSCTC until it became an integral part of the ward 
care process. After the initial training meeting, inter-
vention stroke units were given 4–6 months to implement 
the LSCTC into standard ward practice.
We used the caregiver training record to measure the 
intervention unit’s compliance with LSCTC provision 
and to estimate its costs. The LSCTC developers agreed a 
deﬁ nition of compliance as: indication on the training 
record that training on the six mandatory components 
had been delivered and competency achieved by the 
caregiver, or the record was signed oﬀ  by a member of 
the multidisciplinary team indicating that all necessary 
training had been delivered and competency achieved.
Stroke units randomly assigned to the control group 
were asked to continue usual care as recommended in 
national guidelines.14
Patient baseline data included: sex, age, ethnic origin, 
education, employment, living arrangements, relationship 
to caregiver, previous stroke, disability before stroke, date 
and type of stroke, test of cognition,15 and language 
impairment. We collected the six components of the 
Edinburgh stroke casemix adjuster16 to enable adjust-
ment for stroke severity. For the caregiver, we recorded 
sex, age, ethnic origin, physical ability (modiﬁ ed Rankin 
scale), education, and employment. We noted the inci-
dence of falls between recruitment and discharge as an 
expected serious adverse event.
We recorded primary and secondary outcomes via 
self-completed questionnaires in hospital at baseline, 
and via postal questionnaires at 6 and 12 months. Where 
the patient was unable to complete the question naire 
independently, the caregiver could provide help or 
complete the questionnaire by proxy. We compared 
details of proxy completion between the two groups of 
the study.
For the protocol review in 
The Lancet see http://www.
thelancet.com/protocol-
reviews/10PRT-2438
See Online for appendix
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 Figure 1: Trial proﬁ le
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Statistical analysis
The primary outcome for patients was self-reported 
functional independence in extended activities of daily 
living (ADL) measured at 6 months after recruitment 
using the Nottingham Extended Activities of Daily Living 
(NEADL).17,18 The primary outcome for caregivers was self-
reported burden using the caregivers burden scale (CBS) 
measured at 6 months.19 Secondary outcomes for patients 
were self-reported versions of: the hospital anxiety and 
depression scale (HADS), EQ-5D and quality-adjusted 
life-years (QALYs) generated from it using societal 
weights, Barthel Index, and Stroke Impact Scale (SIS).20–23 
Secondary outcomes for caregivers were self-report 
versions of Frenchay activities index,24 HADS, and EQ-5D 
and QALYs generated from it. We used an adapted self-
complete client service receipt inventory (CSRI) to 
measure patient and caregiver resource use (use of 
services before stroke and after discharge).11,25 We recorded 
patient and caregiver deaths, hospital readmissions, and 
institution alisations. We obtained process data before, 
during, and after recruitment at every participating stroke 
unit to monitor any changes in eligibility in stroke units 
and in the process of care that prepared patients and 
caregivers for discharge in those units.
We calculated that 36 stroke units, each recruiting 
25 patients, resulting in 450 patients per group, would 
provide close to 90% power at 5% signiﬁ cance level to 
detect a six-point diﬀ erence on the NEADL, a diﬀ erence 
agreed as clinically relevant.26 The sample size 
incorporated an inﬂ ation factor of 1·9 due to clustering 
(cluster size of 19 after loss to follow-up; intracluster 
correlation coeﬃ  cient (ICC) no greater than 0·05)27 and 
25% loss to follow-up. The power of the trial was 
adversely aﬀ ected by a higher than expected loss to 
follow-up and unequal cluster sizes. By estimating 
maximum and minimum cluster sizes the predicted 
imbalance decreased the power by 1–3%. To preserve 
ﬁ nal power of 90%, we increased the trial sample size 
from 900 to 950 patient and caregiver dyads, allowing up 
to 35 dyads per stroke unit to compensate for lower 
recruitment at some centres.
We undertook analyses and data summaries on an 
intention-to-treat basis—we analysed all patients 
registered for active follow-up within a stroke unit 
according to the group that that stroke unit was randomly 
assigned to, regardless of non-compliance. We did all 
statistical testing at a 2-sided 5% signiﬁ cance level.
Since the trial was cluster randomised, we compared 
the primary outcome measures, the 6-month NEADL 
score and the CBS, between the intervention and control 
groups using a two-level hierarchical model, with 
patients (or caregivers) nested within stroke units. We 
adjusted for patient-level baseline covariates (baseline 
NEADL, sex, caregiver’s education, caregiver baseline 
HADS score, Edinburgh stroke casemix adjuster), and 
stroke unit-level covariates (geographical region, key 
12 indicator score, and number of beds in every centre) 
in the model. We analysed secondary outcomes for 
patients and caregivers using similar multilevel models. 
We reported eﬀ ect sizes, 95% CIs, and adjusted ICCs. 
We summarised death, hospital admission, and 
institution alisation by treatment group but undertook no 
formal statistical comparison between the intervention 
and control groups.
We did the analyses assuming data missing completely 
at random using complete cases. We used various 
sensitivity analyses to examine the robustness of the 
conclusions of the primary analysis, a sensitivity analysis 
including patients who had died (assuming a NEADL 
score of 0), a repeat of the primary analysis assuming 
data are missing at random, and a sensitivity analysis 
excluding proxy responses. A secondary analysis explored 
the relationship between outcome and com pliance with 
the LSCTC.
Economic evaluation
The prospective economic evaluation assessed the cost-
eﬀ ectiveness of the LSCTC for patients and caregivers at 
6 months (appendix). We combined patient and caregiver 
health and social care service and societal costs with 
NEADL (patient), CBS (caregiver), and QALY outcomes. 
We attached unit costs to individual-level resource use 
quantities to calculate a cost per participant. We included 
the development and staﬀ  training costs associated with 
Intervention 
(n=450)
Control 
(n=478)
Age 71·0 (12·76) 71·3 (12·18)
NEADL score before stroke 52·0 (15·77) 52·3 (15·80)
Barthel index score after stroke 12·2 (5·38) 12·6 (5·45)
Women 193 (43%) 216 (45%)
Language impairment* 118 (26%) 112 (23%)
Cognitive impairment† 135/370 (36%) 145/391 (37%)
Patient relationship to caregiver
Partner 314 (70%) 315 (66%)
Daughter or son 118 (26%) 135 (28%)
Other 18 (4%) 28 (6%)
Data are mean (SD) or number of patients (%). NEADL=Nottingham extended 
activities of daily living. *Includes patients with dysphasia or receptive aphasia. 
†Of those able to express verbally or in writing (as measured by 6-item cognitive 
impairment test).
Table 1: Baseline characteristics and clinical details of patients 
Intervention 
(n=450)
Control 
(n=478)
Age (years) 61·1 (14·64) 60·8 (13·91)
Women 310 (69%) 325 (68%)
Number of individuals having left 
education at age 16 years or younger
317 (70%) 339 (71%)
Data are mean (SD) or number of individuals (%).
Table 2: Baseline characteristics of caregivers
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the LSCTC. We compared costs and QALYs and examined 
the probability of cost-eﬀ ectiveness by constructing cost-
eﬀ ectiveness acceptability curves using threshold ranges 
of £0–2000 for point gains on the NEADL and CBS and 
£0–50 000 for QALY gains. This trial is registered with 
controlled-trials.com, number ISRCTN 49208824.
Role of the funding source
The trial was a major collaborative eﬀ ort with colleagues 
in the National Institute for Health Research (NIHR) 
Stroke Research Network. The sponsor of the study had 
no role in study design, data collection, data analysis, 
data interpretation, or writing of the report. The 
corresponding author had full access to all the data in the 
study and had ﬁ nal responsibility for the decision to 
submit for publication. AP had full access to the health 
economics data. AFa had full access to all the data and 
acts as statistical guarantor.
Results
36 UK stroke units in four geographical regions 
(Yorkshire, the North West, the South West Peninsula, 
and London and the southeast) were randomised in the 
trial. 49 stroke units in these regions expressed an 
interest in TRACS, 41 completed feasibility question-
naires, 39 were eligible, and 36 completed approval 
processes in time to be entered for randomisation 
(ﬁ gure 1). Between Feb 27, 2008, and Feb 9, 2010, 
12 510 patients and caregivers were screened, and 
928 patient and caregiver dyads were registered in the 
trial (450 in the intervention group, 478 in the control 
group), 35% of the 2675 eligible patient and caregiver 
dyads (ﬁ gure 1). The groups were well balanced at 
baseline (tables 1 and 2, appendix). There were more 
male patients than female patients in both groups. 
Caregivers were younger than patients, most caregivers 
had left education at age 16 years or younger, more 
women than men were acting as caregivers in both 
groups, and in most cases they were the patients’ partner. 
The response rates for the endpoints at 6 and 12 months 
were: 690 (74%) of 928 patients at 6 months (335 patients 
in intervention group and 355 patients in control group) 
and 638 (69%) of 928 patients at 12 months (305 patients 
in intervention group and 333 patients in control 
group), and 673 (73%) of 928 caregivers at 6 months 
(329 caregivers in intervention group and 344 caregivers 
in control group) and 609 (66%) of 928 caregivers at 
12 months (295 caregivers in intervention group and 
314 caregivers in control group). 
The patient primary outcome of the NEADL score at 
6 months did not diﬀ er signiﬁ cantly between groups, 
neither did the caregiver primary outcome of the CBS at 
6 months (table 3). We also noted no diﬀ erences in 
patient and caregiver secondary endpoints at 6 or 
12 months (appendix). Sensitivity analyses done on the 
primary outcomes conﬁ rmed the conclusions of the 
primary analyses (data not shown).
Average intervention compliance was 44% (196 of 450); 
half the participating centres had a compliance rating of 
more than 60%. 124 (28%) of 450 training records 
were not completed by the sites (appendix). Results from 
an exploratory analysis showed no relation between 
increased patient functional independence or lower care-
giver burden in stroke units with greater intervention 
com pliance (appendix). Intervention delivery was not 
associated with increased risk of inpatient falls (50 in the 
intervention group vs 42 in the control group). The 
number of deaths, hospital readmissions, or institution-
alisation rates did not diﬀ er between the intervention 
and control groups at either 6 or 12 months after 
registration (data not shown). The process data revealed 
changes to inpatient care in just one centre; carer 
involvement was reduced in an intervention centre (data 
not shown).
The mean cost per patient of the LSCTC training and 
development was £82 in those receiving inputs and £39 
when including zero costs for those either receiving no 
LSCTC inputs or with missing data regarding such 
Intervention Control Diﬀ erence 
(SE)
95 % CI of the 
diﬀ erence
p value Adjusted 
ICC
Mean (SE) N Mean (SE) N
NEADL score 27·4 (1·00) 330 27·6 (0·99) 348 –0·2 (1·34) –3·0 to 2·5 0·866 0·027
Total CBS 
score
45·5 (0·83) 325 45.0 (0·83) 340 0·5 (1·08) –1·7 to 2·7 0·660 0·013
NEADL=Nottingham extended activities of daily living. CBS=caregiver burden scale. ICC=intraclass correlation coeﬃ  cient.
Table 3: Primary outcomes, adjusted scores, diﬀ erences, p values, and ICC according to questionnaire
Figure 2: Probability that the intervention is cost eﬀ ective compared with the control at 6 months, from 
every cost perspective, for a range of willingness to pay values for an additional QALY
QALY=quality-adjusted life-year.
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inputs. The length of the initial stroke admission and 
associated costs were similar in both groups (£13 127 for 
the intervention group and £12 471 for the control group; 
adjusted mean diﬀ erence £1243 [95% CI –1533 to 4019]; 
p=0·380). Total health and social care costs for patients 
and societal costs for patients or caregivers did not diﬀ er 
between groups at 6 months, 12 months, or over 1 year 
(appendix). Caregivers in the intervention group had 
higher health and social care costs at 6 months (adjusted 
mean diﬀ erence £207 [95% CI 5–408], p=0·045). This 
diﬀ erence was no longer present at 12 months or over 
1 year (appendix). We noted no evidence of signiﬁ cant 
diﬀ erences in QALYs for patients or caregivers at any 
assessment point (appendix).
For the threshold ranges examined, probabilities of the 
cost-eﬀ ectiveness of the LSCTC in the patient evaluation 
peaked at 51% based on the NEADL. In the caregiver 
evaluation, the probability of cost-eﬀ ectiveness reached 
62% from a health and social care perspective and 68% 
from a societal perspective based on the CBS, although it 
is unknown what the willingness to pay for a CBS point 
improvement would be in practice. From the health and 
social care perspective, probabilities of cost-eﬀ ectiveness 
based on QALYs were low at a maximum of 36% in the 
patient evaluation and just 2% in the caregiver evaluation 
(ﬁ gure 2). Thus the intervention is unlikely to be 
considered cost-eﬀ ective within current policy thresholds 
of £20 000 to £30 000 per QALY gained.
Discussion
A Cochrane review of eight studies (n=1007) examined the 
eﬀ ectiveness of non-pharmacological interventions for 
caregivers of stroke survivors in reducing caregiver 
burden or enhancing caregiver wellbeing.28 The review 
concluded that previous studies have methodological 
limitations; further robust evaluation was required; and 
the eﬀ ects of caregiver interventions on the patient also 
need to be assessed. The LSCTC was the most promising 
intervention reviewed. The TRACS trial was a pragmatic, 
multicentre, cluster randomised controlled trial of the 
LSCTC complex intervention. Patients who had had a 
stroke attending intervention stroke units did not show a 
clinically signiﬁ cant improvement in functional 
independence compared with patients who had had a 
stroke attending the control stroke units at 6 months after 
registration. The burden for caregivers of patients 
attending intervention stroke units did not signiﬁ cantly 
diﬀ er with that of caregivers of patients attending the 
control stroke units at 6 months. Other physical and 
psychological outcomes did not diﬀ er for patients and 
caregivers. Patient costs were similar and caregiver costs 
were higher in the intervention group, and the LSCTC is 
unlikely to be cost eﬀ ective (panel).
The LSCTC was initially assessed in a single-centre 
individually randomised trial that reported a range of 
beneﬁ ts.10 That study involved a smaller cohort of patients 
and caregivers and was delivered by the multidisciplinary 
team who had developed the intervention and who might 
have had particular expertise and commitment. This 
expertise might not have been replicated in the range of 
stroke units who delivered the intervention in this trial. 
In the 10 years since the single-centre study,10 stroke care 
might have improved in a way consistent with some of 
the LSCTC practices. However, our process evaluation 
indicates that it is unlikely that standard care has 
improved to such a degree that caregivers’ needs have 
been successfully met (publication in preparation). It is 
possible that the immediate post-stroke period, when 
potential caregivers are coming to terms with their new 
situation, might not be the ideal time for the delivery of 
structured training. The intervention approach might be 
more relevant if delivered after discharge by community-
based teams.
 The TRACS trial included stroke units from diﬀ erent 
health-care settings (acute and community hospitals in 
rural and urban settings) in four disparate geographical 
regions. Eligibility criteria were purposely inclusive to 
ensure that a representative population of patients who 
have had a stroke was recruited. We were careful to 
choose outcomes that were known to be valid reliable 
and sensitive to change in this population. The numbers 
of participants and their baseline characteristics were 
well balanced between the study groups, demonstrating 
that selection bias was avoided. Loss of power caused by 
the unequal cluster sizes was compensated for by 
increasing recruitment beyond 900. The follow-up rate 
of 75% at 6 months required for the power calculation 
was nearly achieved. We are therefore conﬁ dent that the 
TRACS trial results are robust and generalisable to all 
patients who have had a stroke and their informal 
caregivers in stroke units across the UK.
Panel: Research in context
Systematic Review
A Cochrane review from 201128 has summarised the eﬀ ectiveness of non-pharmacological 
interventions for caregivers of stroke survivors in reducing caregiver burden or enhancing 
caregiver wellbeing.28 In eight randomised trials including 1007 participants, an 
intervention that focused on preparing participants for the work of caring for a stroke 
survivor (the LSCTC) was the most promising intervention. However, the evidence for this 
was from a single-centre randomised trial.10 We searched the scientiﬁ c literature before 
the publication of the Cochrane review28 on the eﬀ ectiveness of caregiver interventions, 
and we identiﬁ ed no eﬀ ective early training programmes for caregivers of patients after 
stroke, other than the LSCTC.
Interpretation
The purpose of TRACS was to assess if the LSCTC continued to show beneﬁ ts to caregivers 
and patients who have had a stroke if implemented as a part of standard practice in stroke 
units across the UK. The TRACS trial (n=928) has almost doubled the sample size of the 
Cochrane Review, providing conclusive evidence that recovery of patients who have had a 
stroke, caregivers’ burden, or other physical and psychological outcomes do not diﬀ er 
between the LSCTC and usual care, nor is the LSCTC cost eﬀ ective when compared with usual 
care. Caregivers need more than just an inpatient structured training programme to improve 
the patients’ and their own outcomes.
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In keeping with the pragmatic nature of the trial, the 
LSCTC intervention was implemented in accord with 
usual NHS practices for a new service initiative and used 
methods that would be acceptable and feasible to 
multidisciplinary teams and NHS management to allow 
widespread dissemination if eﬀ ectiveness was proven. 
The intervention was acceptable to the staﬀ  attending the 
training days, with recognition of the importance of each 
of the core competencies, demonstrating face validity for 
the intervention. The intent was that the training was 
cascaded down by staﬀ  attending the training days to 
other ward colleagues. It might be that this commonly 
used cascade method was not as eﬀ ective as we would 
have wished. A more intensive (but thus less pragmatic 
and more resource intensive) strategy to implement the 
intervention might have been more successful. A 
component of the intervention was the completion of the 
caregiver training record. Completed training records 
were returned to the Trial Manager and included as a 
standard monitoring report to the Trial Management 
Group and Trial Steering Committee. Half of the 
participating centres had a compliance rating of over 
60%. Such a compliance rate is compatible with other 
trials assessing complex interventions in stroke 
rehabilitation.29 Some units did not implement the 
LSCTC as robustly as envisaged, however, analyses of 
patient independence and caregiver burden showed no 
associations with levels of intervention compliance.
In conclusion, we have undertaken a robust 
multicentre, cluster randomised trial, showing that this 
method is feasible in stroke rehabilitation research. The 
intervention was associated with beneﬁ ts in a single-
centre evaluation but these beneﬁ ts have not been 
replicated in this large, pragmatic multicentre trial. 
There was no diﬀ erence between the LSCTC and usual 
care with respect to improving functional independence 
of patients who have had a stroke, reducing caregivers’ 
burden, or improving other physical and psychological 
outcomes, nor is it cost eﬀ ective when compared with 
usual care. Caregivers need more than just an inpatient 
structured training programme to improve the patients’ 
and their own outcomes. The integrated intervention 
approach might be more relevant, whereby initial 
hospital training is supported with follow-up training 
after discharge delivered by community-based teams.
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